Application of nanostructured drug delivery systems in immunotherapy of cancer: a review

References

• Abbasi E, Akbarzadeh A, Kouhi M, Milani M. 2016a. Graphene: synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol. 44:150–156.
   PubMed Web of Science ®Google Scholar
• Abbasi E, Fekri Aval S, Akbarzadeh A, Milani M, Tayefi Nasrabadi H, Hanifepour Y, Nejati-Koshki K, Pashaei-Asl R. 2014. Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett. 9:247.
   PubMed Web of Science ®Google Scholar
• Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H, et al. 2016b. Silver nanoparticles: synthesis, properties, bio-applications and limitations. Crit Rev Microbiol. 42:173–180.
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K. 2014. An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels. Mol Biol Rep. 41:1659–1668.
   PubMed Web of Science ®Google Scholar
• Alimirzalu S, Akbarzadeh A, Abbasian M, Alimohammadi S, Davaran S, Hanifehpour Y, Samiei M, Woo Joo S. 2014. Synthesis and study of physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly(nisopropylacrylamide)for anti-cancer drugs delivery. Asian Pac J Cancer Prev. 15:049–054.
   PubMedGoogle Scholar
• Alizadeh E, Akbarzadeh A, Zarghami N, Baghaban Eslaminejad M, Hashemzadeh S, Nejati-Koshki K. 2014. Up-regulation of liver enriched transcription factors (HNF4a and HNF6) and liver specific microRNA (miR-122) by inhibition of Let-7b in mesenchymal stem cells. Chem Biol Drug Des. 85:600–608.
   Web of Science ®Google Scholar
• Alizadeh E, Eslaminejad MB, Akbarzadeh A, Sadeghi Z, Abasi M, Herizchi R, Zarghami N. 2016. Upregulation of MiR-122 via trichostatin A treatments in hepatocyte-like cells derived from mesenchymal stem cells. Chem Biol Drug Des. 87:296–305.
   PubMed Web of Science ®Google Scholar
• Almeida JPM, Figueroa ER, Drezek RA. 2014. Gold nanoparticle mediated cancer immunotherapy. Nanomed Nanotechnol Biol Med. 10:503–514.
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Jennings GT. 2010. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 10:787–796.
   PubMed Web of Science ®Google Scholar
• Baxevanis CN, Perez SA, Papamichail M. 2009. Cancer immunotherapy. Crit Rev Clin Lab Sci. 46:167–189.
   PubMed Web of Science ®Google Scholar
• Begley J, Ribas A. 2008. Targeted therapies to improve tumor immunotherapy. Clin Cancer Res. 14:4385–4391.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. 2014. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 66:2–25.
   PubMed Web of Science ®Google Scholar
• Bhutia SK, Mallick SK, Maiti TK. 2010. Tumour escape mechanisms and their therapeutic implications in combination tumour therapy. Cell Biol Int. 34:553–563.
   PubMed Web of Science ®Google Scholar
• Chatenoud L. 2006. Immune therapies of autoimmune diseases: are we approaching a real cure? Curr Opin Immunol. 18:710–717.
   PubMed Web of Science ®Google Scholar
• Cho N-H, Cheong T-C, Min JH, Wu JH, Lee SJ, Kim D, et al. 2011. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat Nanotechnol. 6:675–682.
   PubMed Web of Science ®Google Scholar
• Chung J-H, Kim YK, Kim K-H, Kwon T-Y, Vaezmomeni SZ, Samiei M, et al. 2016. Synthesis, characterization, biocompatibility of hydroxyapatite-natural polymers nanocomposites for dentistry applications. Artif Cells Nanomed Biotechnol. 44:277–284.
   PubMed Web of Science ®Google Scholar
• Conniot J, Silva JM, Fernandes JG, Silva LC, Gaspar R, Brocchini S, et al. 2014. Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem. 2:105.
   PubMed Web of Science ®Google Scholar
• Cruz LJ, Rueda F, Cordobilla B, Simón L, Hosta L, Albericio F, et al. 2010. Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy. Mol Pharm. 8:104–116.
   PubMed Web of Science ®Google Scholar
• Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2016a. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 44:410–422.
   PubMed Web of Science ®Google Scholar
• Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2016b. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 44:381–391.
   PubMed Web of Science ®Google Scholar
• Davoudi Z, Akbarzadeh A, Rahmatiyamchi M, Akbar Movassaghpour A, Alipour M, Nejati-Koshki K, et al. 2014. Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells. Asian Pac J Cancer Prev. 15:4353.
   PubMedGoogle Scholar
• Dimberu PM, Leonhardt RM. 2011. Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear. Yale J Biol Med. 84:371.
   PubMedGoogle Scholar
• Dunn GP, Old LJ, Schreiber RD. 2004. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 21:137–148.
   PubMed Web of Science ®Google Scholar
• Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, Hanifehpour Y, Woo Joo S. 2014. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. 9:1–13.
   PubMed Web of Science ®Google Scholar
• Eatemadi A, Daraee H, Zarghami N, Melat Yar H, Akbarzadeh A, Hanifehpour Y. 2016. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. 44:111–121.
   Google Scholar
• Ebrahimi E, Abbasi E, Akbarzadeh A, Ahmad Khandaghi A, Davaran S. 2016. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol. 44:290–287.
   PubMed Web of Science ®Google Scholar
• Effat A, Zarghami N, Eslaminejad MB, Akbarzadeh A, Barzegar A, Abolghasem Mohammadi S. 2016. The effect of dimethyl sulfoxide (DMSO) on hepatic differentiation of mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 44:157–164.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. 2011. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 63:136–151.
   PubMed Web of Science ®Google Scholar
• Fekri Aval S, Akbarzadeh A, Yamchi MR, Zarghami F, Nejati-Koshki K, Zarghami N. 2016. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line. Artif Cells Nanomed Biotechnol. 44:188–193.
   PubMed Web of Science ®Google Scholar
• Ghasemali S, Nejati-Koshki K, Akbarzadeh A, Tafsiri E, Zarghami N, Rahmati-Yamchi M, et al. 2013. Study of inhibitory effect of β-cyclodextrin-helenalin complex on HTERT gene expression in T47D breast cancer cell line by real timequantitative PCR (q-PCR). Asian Pac J Cancer Prev. 14:6949–6953.
   PubMedGoogle Scholar
• Hanes J, Sills A, Zhao Z, Suh KW, Tyler B, DiMeco F, et al. 2001. Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Pharm Res. 18:899–906.
   PubMed Web of Science ®Google Scholar
• Hosseininasab S, Pashaei-Asl R, Ahmad Khandaghi A, Tayefi Nasrabadi H, Nejati-Koshki K, Akbarzadeh A, et al. 2014. Synthesis, characterization, and in vitro studies of PLGA-PEG nanoparticles for oral Insulin delivery. Chem Biol Drug Des. 84:307–315.
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK, El-Sayed IH, El-Sayed MA. 2007. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond). 2:681–693.
   Google Scholar
• Klippstein R, Pozo D. 2010. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomed Nanotechnol Biol Med. 6:523–529.
   PubMed Web of Science ®Google Scholar
• Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Woo Joo S. 2014. Investigation of quadratic electro-optic effects and electro absorption process in GaN/AlGaN spherical quantum dot. Nanoscale Res Lett. 9:131–136.
   PubMed Web of Science ®Google Scholar
• Lee I-H, An S, Yu MK, Kwon H-K, Im S-H, Jon S. 2011. Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates. J Control Release. 155:435–441.
   PubMed Web of Science ®Google Scholar
• Liu S-Y, Wei W, Yue H, Ni D-Z, Yue Z-G, Wang S, et al. 2013. Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy. Biomaterials. 34:8291–8300.
   PubMed Web of Science ®Google Scholar
• Malyala P, O’Hagan DT, Singh M. 2009. Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles. Adv Drug Deliv Rev. 61:218–225.
   PubMed Web of Science ®Google Scholar
• Mejías R, Pérez-Yagüe S, Gutiérrez L, Cabrera LI, Spada R, Acedo P, et al. 2011. Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy. Biomaterials. 32:2938–2952.
   PubMed Web of Science ®Google Scholar
• Mellman I, Coukos G, Dranoff G. 2011. Cancer immunotherapy comes of age. Nature. 480:480–489.
   PubMed Web of Science ®Google Scholar
• Nasrabadi HT, Abbasi E, Davaran S, Kouhi M, Akbarzadeh A. 2016. Bimetallic nanoparticles: preparation, properties, and biomedical applications. Artif Cells Nanomed Biotechnol. 44:376–380.
   PubMed Web of Science ®Google Scholar
• Natasha G, Gundogan B, Tan A, Farhatnia Y, Wu W, Rajadas J, et al. 2014. Exosomes as immunotheranostic nanoparticles. Clin Therap. 36:820–829.
   PubMed Web of Science ®Google Scholar
• Nikpoor AR, Tavakkol-Afshari J, Gholizadeh Z, Sadri K, Babaei MH, Chamani J, et al. 2015. Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model. Int J Pharm. 495:162–170.
   PubMed Web of Science ®Google Scholar
• Noh YW, Hong JH, Shim SM, Park HS, Bae HH, Ryu EK, et al. 2013. Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity. Angewandte Chem. 125:7838–7843.
   Google Scholar
• Park Y-M, Lee SJ, Kim YS, Lee MH, Cha GS, Jung ID, et al. 2013. Nanoparticle-based vaccine delivery for cancer immunotherapy. Immune Netw. 13:177–183.
   PubMedGoogle Scholar
• Paulis LE, Mandal S, Kreutz M, Figdor CG. 2013. Dendritic cell-based nanovaccines for cancer immunotherapy. Curr Opin Immunol. 25:389–395.
   PubMed Web of Science ®Google Scholar
• Peng BG, Liu SQ, Kuang M, He Q, Totsuka S, Huang L, et al. 2002. Autologous fixed tumor vaccine: a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma. Jpn J Cancer Res. 93:363–368.
   PubMedGoogle Scholar
• Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, de la Guardia M, Nejati-Koshki K. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. IET Dig Library. 4:5.
   Google Scholar
• Shen H, Ackerman AL, Cody V, Giodini A, Hinson ER, Cresswell P, et al. 2006. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology. 117:78–88.
   PubMed Web of Science ®Google Scholar
• Sheng W-Y, Huang L. 2011. Cancer immunotherapy and nanomedicine. Pharm Res. 28:200–214.
   PubMed Web of Science ®Google Scholar
• Silva JM, Videira M, Gaspar R, Préat V, Florindo HF. 2013. Immune system targeting by biodegradable nanoparticles for cancer vaccines. J Control Release. 168:179–199.
   PubMed Web of Science ®Google Scholar
• Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, Badrzadeh F, Rahmati-Yamchi M. 2016. A comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 44:423–430.
   PubMed Web of Science ®Google Scholar
• Tran T-H, Mattheolabakis G, Aldawsari H, Amiji M. 2015. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases. Clin Immunol. 160:46–58.
   PubMed Web of Science ®Google Scholar
• Weiner LM, Surana R, Wang S. 2010. Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nat Rev Immunol. 10:317–327.
   PubMed Web of Science ®Google Scholar
• Yan W, Chen W, Huang L. 2008. Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine. J Control Release. 130:22–28.
   PubMed Web of Science ®Google Scholar
• Yim H, Park W, Kim D, Fahmy TM, Na K. 2014. A self-assembled polymeric micellar immunomodulator for cancer treatment based on cationic amphiphilic polymers. Biomaterials. 35:9912–9919.
   PubMed Web of Science ®Google Scholar
• Yoshizaki Y, Yuba E, Sakaguchi N, Koiwai K, Harada A, Kono K. 2014. Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy. Biomaterials. 35:8186–8196.
   PubMed Web of Science ®Google Scholar
• Yuba E, Harada A, Sakanishi Y, Watarai S, Kono K. 2013. A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy. Biomaterials. 34:3042–3052.
   PubMed Web of Science ®Google Scholar
• Yuba E, Tajima N, Yoshizaki Y, Harada A, Hayashi H, Kono K. 2014. Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy. Biomaterials. 35:3091–3101.
   PubMed Web of Science ®Google Scholar
• Zupančič E, Silva J, Videira MA, Moreira JN, Florindo HF. 2014. Development of a novel nanoparticle-based therapeutic vaccine for breast cancer immunotherapy. Proc Vaccinol. 8:62–67.
   Google Scholar